Please login to the form below

Not currently logged in
Email:
Password:

Evenity

This page shows the latest Evenity news and features for those working in and with pharma, biotech and healthcare.

UCB/Amgen’s Evenity finally cleared for osteoporosis in Europe

UCB/Amgen’s Evenity finally cleared for osteoporosis in Europe

UCB and Amgen have finally claimed European approval for their osteoporosis drug Evenity, which becomes the first new drug for the disease in the EU since 2010. ... Anti-sclerostin antibody Evenity (romosozumab) – which works by increasing bine

Latest news

More from news
Approximately 5 fully matching, plus 4 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

Switzerland
Switzerland: a life sciences hub
Switzerland has a rich diversity of pharma and biotech companies that sustain activity and help maintain its reputation as a highly innovative country...
Responding to dynamic shifts in value communications
OPEN Health’s Beth Lesher and Annemarie Clegg examine what the convergence of medical communications and market access means for pharmaceutical companies....
Doing what we can and having fun doing it: our fundraising month
Charities are facing a number of challenges just to stay afloat amidst the current COVID-19 pandemic. Fundraisers are being cancelled and public donations are not as abundant as they have...

Infographics